Clinical Trial Update: A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence [Phase 2]

View source ↗

Summary

A Phase 2, multicenter, randomized, blinded trial evaluating Durasphere FI for fecal incontinence was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• Durasphere FI

Snippet

Sponsor: Carbon Medical Technologies | Conditions: Fecal Incontinence | Phase 2 | Status: TERMINATED